 ALISO VIEJO, Calif., Jan. 08, 2023 GLOBE NEWSWIRE NASDAQ: RXST RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth quarter and full-year 2022. Preliminary Unaudited Results Preliminary unaudited fourth quarter 2022 revenue is expected ... The post RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year... 